Cargando…

Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series

BACKGROUND: Random-start, controlled ovarian stimulation (COS) has advanced the field of fertility preservation, allowing patients to expedite fertility treatment and avoid further delays to their cancer therapy. This novel approach allows patients to initiate ovarian stimulation at any point, regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Miguel, Liu, Kimberly, Chan, Crystal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273650/
https://www.ncbi.nlm.nih.gov/pubmed/32503566
http://dx.doi.org/10.1186/s12958-020-00614-y
_version_ 1783542446029799424
author Russo, Miguel
Liu, Kimberly
Chan, Crystal
author_facet Russo, Miguel
Liu, Kimberly
Chan, Crystal
author_sort Russo, Miguel
collection PubMed
description BACKGROUND: Random-start, controlled ovarian stimulation (COS) has advanced the field of fertility preservation, allowing patients to expedite fertility treatment and avoid further delays to their cancer therapy. This novel approach allows patients to initiate ovarian stimulation at any point, regardless of where they are in their menstrual cycle. Luteal-phase start (LPS) protocols describe treatment cycles where COS is initiated during the luteal-phase of the menstrual cycle. LPS protocols have not been studied or optimized to the same degree as conventional, early-follicular COS. Particularly, there is a paucity of evidence evaluating treatment outcomes using different trigger medications in LPS protocols. The present study aims to evaluate the efficacy of using a GnRH agonist (GnRH-a) trigger in patients undergoing oocyte cryopreservation in LPS protocols. METHODS: This descriptive case series describes two patients, recently diagnosed with cancer, who underwent oocyte cryopreservation using an LPS protocol and a GnRH-a trigger at a university-affiliated, academic center. RESULTS: The patients described in our case series both failed to adequately respond to a GnRH-a trigger, based on their serum levels of luteinizing hormone (LH) and progesterone 12 h after their GnRH-a trigger. They both required a single rescue dose of human chorionic gonadotropin (hCG). CONCLUSIONS: These findings highlight the potential risk of a suboptimal response to a GnRH-a trigger in patients undergoing LPS, controlled ovarian stimulation for oocyte cryopreservation. This risk might be attributed to the downregulation of GnRH receptors by elevated serum progesterone levels during the luteal phase. Currently, there is insufficient evidence to recommend for or against the use of a GnRH-a trigger during LPS controlled ovarian stimulation. This case series offers a number of management strategies to mitigate this risk and emphasizes the need for further research in this area.
format Online
Article
Text
id pubmed-7273650
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72736502020-06-08 Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series Russo, Miguel Liu, Kimberly Chan, Crystal Reprod Biol Endocrinol Research BACKGROUND: Random-start, controlled ovarian stimulation (COS) has advanced the field of fertility preservation, allowing patients to expedite fertility treatment and avoid further delays to their cancer therapy. This novel approach allows patients to initiate ovarian stimulation at any point, regardless of where they are in their menstrual cycle. Luteal-phase start (LPS) protocols describe treatment cycles where COS is initiated during the luteal-phase of the menstrual cycle. LPS protocols have not been studied or optimized to the same degree as conventional, early-follicular COS. Particularly, there is a paucity of evidence evaluating treatment outcomes using different trigger medications in LPS protocols. The present study aims to evaluate the efficacy of using a GnRH agonist (GnRH-a) trigger in patients undergoing oocyte cryopreservation in LPS protocols. METHODS: This descriptive case series describes two patients, recently diagnosed with cancer, who underwent oocyte cryopreservation using an LPS protocol and a GnRH-a trigger at a university-affiliated, academic center. RESULTS: The patients described in our case series both failed to adequately respond to a GnRH-a trigger, based on their serum levels of luteinizing hormone (LH) and progesterone 12 h after their GnRH-a trigger. They both required a single rescue dose of human chorionic gonadotropin (hCG). CONCLUSIONS: These findings highlight the potential risk of a suboptimal response to a GnRH-a trigger in patients undergoing LPS, controlled ovarian stimulation for oocyte cryopreservation. This risk might be attributed to the downregulation of GnRH receptors by elevated serum progesterone levels during the luteal phase. Currently, there is insufficient evidence to recommend for or against the use of a GnRH-a trigger during LPS controlled ovarian stimulation. This case series offers a number of management strategies to mitigate this risk and emphasizes the need for further research in this area. BioMed Central 2020-06-05 /pmc/articles/PMC7273650/ /pubmed/32503566 http://dx.doi.org/10.1186/s12958-020-00614-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Russo, Miguel
Liu, Kimberly
Chan, Crystal
Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series
title Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series
title_full Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series
title_fullStr Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series
title_full_unstemmed Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series
title_short Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series
title_sort suboptimal response to gnrh-agonist trigger during oocyte cryopreservation: a case series
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273650/
https://www.ncbi.nlm.nih.gov/pubmed/32503566
http://dx.doi.org/10.1186/s12958-020-00614-y
work_keys_str_mv AT russomiguel suboptimalresponsetognrhagonisttriggerduringoocytecryopreservationacaseseries
AT liukimberly suboptimalresponsetognrhagonisttriggerduringoocytecryopreservationacaseseries
AT chancrystal suboptimalresponsetognrhagonisttriggerduringoocytecryopreservationacaseseries